Well, the Patent Baristas website was hacked. Dang! I know everyone says this but I really didn’t think it could happen to us. We’re so small and do not have any commercial component, who would really care about hacking this site? It turns out that hacking is indiscriminate. I discovered a malware on the website […]

The U.S. Commerce Department’s United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO)  announced publication of a classification system meant to speed the patent granting process for applicants to both Offices. The Cooperative Patent Classification (CPC) system and finalized CPC definitions are now available in advance of the January 1, 2013, […]

Patexia is offering a $5000 prize to the winner of a research contest involving charge pumps in voltage controlled oscillators. The goal is to find relevant, published material pre-dating a certain patent. This is a chance to win money, to tackle a real problem, to showcase your technical skills, and to gain visibility in the […]

It’s day numbah five until BIO 2012 Convention hits beantown in a flurry of activity, Chris Christie, the Republican governor of New Jersey known for his combative style, was named the BIO 2012 Governor of the Year. The Award was presented to Governor Christie at a special ceremony at the State House in Trenton joined […]

“Behind many extraordinary innovations there are extraordinary human stories.” ~Francis Gurry, Director General of WIPO On April 26, 2012, WIPO celebrates World Intellectual Property Day.  The theme of World IP Day this year is “Visionary Innovators”.  Behind every great innovation, either artistic or technological, is a human story – a tale in which new pathways […]

As reported in the Atlantic, applicants to law school are down 15.6 percent for the year. Bigger problem? The wrong students may have stopped applying. The smallest drop in applications (4.3%) was among test takers who scored below a 144. Meanwhile, applicants in the 170-174 range are down by more than 20 percent. The Law […]

More commentary on the compulsory license granted by the Indian Patent Office for Bayer’s drug Sorafenib Tosylate (Nexavar): I read your follow-up post on compulsory licensing.  In it, you state that average income in India is $8000.  I have no idea what your source is, but you are regrettably wrong.  Average gross salary in India […]

Well, I’ve certainly heard from a number of people regarding my earlier post on  the compulsory license granted by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of Bayer’s drug Sorafenib Tosylate (Nexavar), a drug used to treat liver and kidney cancer. The gist of the complaints are that I’m […]